Fundraising Fox

Biolase

Irvine, US · Delaware corporation

Healthtech

Founders & leadership

JRJohn R. Beaver
John R. BeaverinExecutive
JT
Jonathan T. Lord, M.D.Named on SEC filing
EC
Elaine C. Wagner, D.D.S.Named on SEC filing
GS
Garrett SatoNamed on SEC filing
JR
Jess RoperNamed on SEC filing
TA
Todd A. NorbeNamed on SEC filing
RB
Richard B. Lanman, M.D.Named on SEC filing

Reported raises · per SEC filings

Form D private placements

$13.6M disclosed across 3 rounds · 2019–2023

▶$2.7MraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John R. BeaverExecutive Officer, Director
  • Jonathan LordDirector
  • Kathleen T. O'LoughlinDirector
  • Kenneth P. YaleDirector
  • Jess RoperDirector
  • Jennifer BrightExecutive Officer
  • Martha SomermanDirector
  • Carol Gomez SummerhaysDirector
Offering amount
$2.7M
Amount sold
$2.7M
Sales commissions
$96K
Placement agents
Maxim Group LLC
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.9MraisedJun 2020 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard B. LanmanDirector
  • Jess RoperDirector
  • Elaine C. WagnerDirector
  • Michael DiTollaDirector
  • Garrett SatoDirector
  • John R. BeaverExecutive Officer
  • Jonathan T. LordDirector
  • Todd A. NorbeExecutive Officer, Director
Offering amount
$6.9M
Amount sold
$6.9M
Sales commissions
$483.8K
Placement agents
The Benchmark Company LLC, Colliers Securities LLC
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedNov 2019 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan T. Lord, M.D.Director
  • Elaine C. Wagner, D.D.S.Director
  • Garrett SatoDirector
  • Jess RoperDirector
  • Todd A. NorbeExecutive Officer, Director
  • John R. BeaverExecutive Officer
  • Richard B. Lanman, M.D.Director
Offering amount
$4M
Amount sold
$4M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Biolase Raises $7 Million, Expands Capital and Ensures Compliance - TipRanks.comtipranks.com · Feb 2024Biolase: Business Recovery On The Way But Warrant Overhang Should Keep Investors Sidelined (NASDAQ:BIOL) | Seeking Alphaseekingalpha.com · Feb 2021Biolase Raises $18M - Orange County Business Journalocbj.com · Jul 2020

Frequently asked questions

How much funding has Biolase raised?
Biolase has disclosed $13.6M raised across 3 rounds.
Where is Biolase headquartered?
Biolase is headquartered in Irvine, US.